These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 1280574

  • 1. Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors.
    Lebovitz HE.
    Drugs; 1992; 44 Suppl 3():21-8. PubMed ID: 1280574
    [Abstract] [Full Text] [Related]

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 3. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes.
    Scheen AJ, Castillo MJ, Lefèbvre PJ.
    Acta Clin Belg; 1993; 48(4):259-68. PubMed ID: 8212978
    [Abstract] [Full Text] [Related]

  • 4. Oral antidiabetic agents. A guide to selection.
    Scheen AJ, Lefèbvre PJ.
    Drugs; 1998 Feb; 55(2):225-36. PubMed ID: 9506242
    [Abstract] [Full Text] [Related]

  • 5. Antihyperglycaemic agents. Drug interactions of clinical importance.
    Scheen AJ, Lefèbvre PJ.
    Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982
    [Abstract] [Full Text] [Related]

  • 6. Oral antidiabetic drugs: an overview.
    Melander A.
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S143-7. PubMed ID: 8894498
    [Abstract] [Full Text] [Related]

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Sep; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 8. Management of non-insulin-dependent diabetes mellitus.
    Lefèbvre PJ, Scheen AJ.
    Drugs; 1992 Sep; 44 Suppl 3():29-38. PubMed ID: 1280575
    [Abstract] [Full Text] [Related]

  • 9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 10. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ, Ferner RE, Bailey CJ.
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [Abstract] [Full Text] [Related]

  • 11. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW.
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [Abstract] [Full Text] [Related]

  • 12. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH, van Haeften TW.
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [Abstract] [Full Text] [Related]

  • 13. Effects of current therapeutic interventions on insulin resistance.
    Kobayashi M.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S32-40. PubMed ID: 11220286
    [Abstract] [Full Text] [Related]

  • 14. Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies.
    Yki-Järvinen H.
    Diabet Med; 1997 Aug; 14 Suppl 3():S32-7. PubMed ID: 9272611
    [Abstract] [Full Text] [Related]

  • 15. The use of sulphonylureas in the elderly.
    Graal MB, Wolffenbuttel BH.
    Drugs Aging; 1999 Dec; 15(6):471-81. PubMed ID: 10641958
    [Abstract] [Full Text] [Related]

  • 16. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
    Jennings PE.
    Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D, Kahn SE.
    Am J Med; 1991 Jun 24; 90(6A):8S-14S. PubMed ID: 1872310
    [Abstract] [Full Text] [Related]

  • 18. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ, Peters DH.
    Drugs; 1995 May 24; 49(5):721-49. PubMed ID: 7601013
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
    Lebovitz HE.
    Cleve Clin J Med; 2002 Oct 24; 69(10):809-20. PubMed ID: 12371804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.